Minicast: Pharmaceutical Breakthoughs for Treating Alzheimer's

In this Fight Back Minicast episode, our special guest, Claire Day, discusses the symptoms of Alzheimer’s and how it differs from dementia and answers questions about the newly FDA-approved treatment for Alzheimer’s.
 
Claire has been on the staff of the Alzheimer’s Association since 2001. She is currently the Chief Program Officer at the Northern California and Northern Nevada Chapter. Claire oversees all clinical operations and service delivery throughout the Chapter’s territory. She and her highly trained staff deliver community social services in the form of education, support, advocacy, and care management to people with Alzheimer’s and their families, as well as to professional caregivers.